Lexapro, manufactured by Forest Laboratories, was prescribed to many pregnant women for depression during pregnancy, and can cause a range of serious birth defects to the infant, particularly if taken during the first trimester. After the drug was approved in 2002, it was widely marketed, without informing many potential patients of its side effects. Forest Pharmaceuticals has already paid over $313 million to the U.S. Department of Justice for marketing Lexapro for unapproved uses; but, they remain legally responsible for the damages inflicted on mothers and infants who have suffered because of the drug’s effects
Birth Defects caused by Lexapro can include:
- Congenital heart defects and anomalies
- Persistent pulmonary hypertension of the newborn (PPHN)
- Down’s syndrome
- Undescended testes
- Spina bifida
- Cleft lip or cleft palate
Drug makers have a legal duty to warn about all potential side effects of their medications. Without this full disclosure, a pregnant mother cannot make an informed decision about the potential risk to her unborn child. When this information is kept from her and the baby is born with defects due to the drug, the company may be held liable.
The Court rulings in the Hudson County, New Jersey Lexapro cases against Forest Laboratories represents the first time that a court in the United States has ruled that the expert testimony against Lexapro is sufficient to be able to take a case to trial. Rulings in other jurisdictions unfortunately shielded Forest Laboratories from liability.
If you have taken Lexapro while pregnant or have any other questions, please contact Frank Rodriguez at (201) 876-8930 or firstname.lastname@example.org.